Management of Muscle Stiffness

Appropriate Treatments

• The American family physician guidelines recommend avoiding benztropine in elderly patients with muscle stiffness, due to its anticholinergic effects and lack of direct muscle relaxant properties 1
• Baclofen is the preferred first-line agent for true muscle spasm, with documented efficacy particularly in chronic conditions, at doses of 10-30 mg/day 2
• Tizanidine is an alternative first-line option, especially for chronic stroke patients with spasticity, starting at 2 mg up to three times daily with slow titration 2
• The American Geriatrics Society recommends avoiding muscle relaxants as a class in elderly patients due to increased risk of falls, sedation, and anticholinergic effects 4

Medications to Avoid

• Carisoprodol should be avoided due to abuse concerns, as it has been removed from the European market 5
• Cyclobenzaprine should be avoided due to its structural similarity to tricyclic antidepressants and comparable adverse effects 4
• Benzodiazepines should be avoided during stroke recovery, as they may have deleterious effects on recovery 2

Non-Pharmacologic Approaches

• Non-pharmacological interventions, including stretching, massaging affected muscles, and application of ice, should accompany any drug therapy 2

Clinical Pitfalls to Avoid

• Baclofen and other muscle relaxants should not be abruptly discontinued after prolonged use, to prevent withdrawal symptoms including CNS irritability 5
• Benztropine should not be prescribed with the mistaken belief it relieves muscle spasm, as its effects are nonspecific and not related to muscle relaxation 5
• Patients using tizanidine should be monitored for orthostatic hypotension and sedation, particularly in renally impaired patients 3
• Combining muscle relaxants with other anticholinergic medications should be avoided to prevent additive adverse effects 3